SP’s Doctor Erik Foehr is a biotechnology expert with over 15 years of research and development experience, resulting in numerous publications, patents, and innovations that propel the advancement of science, medical treatment, and patient care.
Dr. Foehr has a strong scientific background and business acumen that drive effective operations and project management. His work includes contributions in the areas of regulated bioanalysis and medical device characterization. He publishes and presents his work on pharmacokinetics, immunogenicity, and the application of new technologies to product development. Dr. Foehr has served in leadership positions at small start-ups and large biotechnology companies. In his current role as Vice President of Analytical Sciences, he collaborates with hundreds of biotechnology, pharmaceutical, and medical device companies to enable successful product development. He is often called upon to provide expertise and resources needed to solve complex technical problems that threaten product development.
Dr. Foehr actively participates in trade organizations such as the American Association of Pharmaceutical Scientists, Clinical Lab Standards Institute, and Medical Device Manufacturers. His efforts in the biopharmaceutical industry have included successful development and approval of over a dozen drugs and medical devices. He directly contributes to new drug applications with the FDA and European agencies and has hosted regulatory audits from government and industry organizations. Dr. Foehr can help navigate through difficult operational, technical and regulatory challenges faced in the biopharmaceutical and medical device industry.
He received a Ph.D. in Physiology and Biophysics at the University of California, Irvine and Post-Doctoral Fellowship at the Gladstone Institute of Virology and Immunology.